PSME3 gene

Known as: PROTEASOME ACTIVATOR SUBUNIT 3, KI ANTIGEN, REG-GAMMA 
This gene is involved in cell cycle regulation.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1985-2016
02419852016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Proteasome activator subunit 3 (PSME3) plays a key role in breast cancer by regulating the cell cycle. However, its role in other… (More)
Is this relevant?
2016
2016
The NF-κB pathway plays important roles in immune responses. Although its regulation has been extensively studied, here, we… (More)
Is this relevant?
2011
2011
OBJECTIVE Responses to therapies, either with regard to toxicities or efficacy, are expected to involve complex relationships of… (More)
Is this relevant?
2011
2011
The DNA damage response (DDR) is a complex signaling network that leads to damage repair while modulating numerous cellular… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
MAFA is a member of the MAF family of basic leucine zipper transcription factors and is a critical regulator of insulin gene… (More)
Is this relevant?
2011
2011
MAFA is a member of the MAF family of basic leucine zipper transcription factors and is a critical regulator of insulin gene… (More)
Is this relevant?
2010
2010
Butyrylcholinesterase may have a role in a number of metabolic functions and could affect the expression of insulin resistance… (More)
Is this relevant?
2009
2009
REGgamma (also called PA28gamma or PSME3) is a proteasome activator involved in the degradation of several proteins that regulate… (More)
Is this relevant?
2006
2006
The purpose of this study was to identify and validate novel serological protein biomarkers of human colorectal cancer (CRC… (More)
  • table I
  • figure 1
  • table II
  • table II
  • figure 3
Is this relevant?
2000
2000
PA28 is an activator of the latent 20S proteasome, a large multisubunit complex involved in intracellular proteolysis. Two forms… (More)
Is this relevant?